3rd Quarter - Report

QUEST DIAGNOSTICS INCORPORATED for QUEST DIAGNOSTICS INCORPORATED

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$360,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 20, 2025 $360,000 Replaced
3rd Quarter - Amendment Jan 20, 2026 $310,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing

LobbyistCovered position, as disclosed
EMMA LANGE —
SHERRY HARPER WIDICUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation Federal price transparency legislation related to clinical laboratories S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025

LobbyistCovered position, as disclosed
EMMA LANGE —
SHERRY HARPER WIDICUS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5269 (119th), H.R. 5571 (119th), H.R. 3514 (119th), S. 2761 (119th), S. 1816 (119th)

Medicare/Medicaid MMM

P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program

LobbyistCovered position, as disclosed
EMMA LANGE —
SHERRY HARPER WIDICUS —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 6363 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.